These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25232954)
21. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149 [TBL] [Abstract][Full Text] [Related]
22. Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope. D'Ambrosio MV; Bakalar M; Bennuru S; Reber C; Skandarajah A; Nilsson L; Switz N; Kamgno J; Pion S; Boussinesq M; Nutman TB; Fletcher DA Sci Transl Med; 2015 May; 7(286):286re4. PubMed ID: 25947164 [TBL] [Abstract][Full Text] [Related]
23. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events. Fokom-Domgue J; Pion SD; Gounoue R; Akame J; Nguipdop-Djomo P; Twum-Danso NA; Thylefors B; Boussinesq M; Kamgno J Am J Trop Med Hyg; 2014 Feb; 90(2):335-8. PubMed ID: 24420781 [TBL] [Abstract][Full Text] [Related]
24. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793 [TBL] [Abstract][Full Text] [Related]
25. Familial Aggregation and Heritability of Loa loa Microfilaremia. Eyebe S; Sabbagh A; Pion SD; Nana-Djeunga HC; Kamgno J; Boussinesq M; Chesnais CB Clin Infect Dis; 2018 Feb; 66(5):751-757. PubMed ID: 29040446 [TBL] [Abstract][Full Text] [Related]
26. Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas. Niamsi-Emalio Y; Nana-Djeunga HC; Chesnais CB; Pion SDS; Tchatchueng-Mbougua JB; Boussinesq M; Basáñez MG; Kamgno J Clin Infect Dis; 2021 Jun; 72(Suppl 3):S158-S164. PubMed ID: 33909066 [TBL] [Abstract][Full Text] [Related]
27. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279 [TBL] [Abstract][Full Text] [Related]
28. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas. Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025 [TBL] [Abstract][Full Text] [Related]
29. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa. Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406 [TBL] [Abstract][Full Text] [Related]
30. First case of ivermectin-induced severe hepatitis. Veit O; Beck B; Steuerwald M; Hatz C Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):795-7. PubMed ID: 16682062 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon). Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228 [TBL] [Abstract][Full Text] [Related]
32. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Kamgno J; Pion SD; Mackenzie CD; Thylefors B; Boussinesq M Am J Trop Med Hyg; 2009 Dec; 81(6):1056-61. PubMed ID: 19996437 [TBL] [Abstract][Full Text] [Related]
33. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa. Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340 [TBL] [Abstract][Full Text] [Related]
34. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns. Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363 [TBL] [Abstract][Full Text] [Related]
35. Rapid assessment method for prevalence and intensity of Loa loa infection. Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206 [TBL] [Abstract][Full Text] [Related]
36. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon. Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120 [TBL] [Abstract][Full Text] [Related]
37. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371 [TBL] [Abstract][Full Text] [Related]